Neoadjuvant Chemotherapy in Bladder Cancer: A Randomized Study

REFERENCES

• Ahmed T, Yagoda A, Needles B, Scher HI, Watson RC, Geller N. Vinblastine and methotrexate for advanced bladder cancer. J Urol 1984; 133: 602–604.
   Web of Science ®Google Scholar
• Algaba F. Origin of high-grade superficial bladder cancer. Eur Urol 1987; 13: 153–155.
   PubMed Web of Science ®Google Scholar
• Andersson L, Esposti PL, Fosså SD, Sander S. Induction chemotherapy in association with preoperative radiotherapy and cystectomy in bladder carcinoma. Prog Clin Biol Res 1988; 260: 621–623.
   PubMedGoogle Scholar
• Anderström C, Johansson S, Nilsson S, Unsgaard B, Wahlqvist L. A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. Eur Urol 1983; 9: 142–147.
   PubMed Web of Science ®Google Scholar
• Batata MA, Whitmore WFJr, Chu FCH, Hilaris BS, Unal A, Chung S. Patterns of recurrence in bladder cancer treated by irradiation and/or cystectomy. Int J Rad Oncol Biol Phys 1980; 6: 155–159.
   PubMed Web of Science ®Google Scholar
• Birch BRP and Harland SJ. The pT1 G3 bladder tumour. Br J Urol 1989; 64: 109–166.
   PubMedGoogle Scholar
• Crawford ED, Das S, Smith JAJr. Preoperative radiation therapy in the treatment of bladder cancer. Urol Clin North Am 1987; 14: 781–787.
   PubMed Web of Science ®Google Scholar
• Gagliano R, Levin H, El-Bolkainy MN et al. Adriamycin versus adriamycin plus cis-diamminedichloroplatinum in advanced transitional cell bladder cancer. Am J Clin Oncol 1983; 6: 215–219.
   PubMed Web of Science ®Google Scholar
• Harker WG, Meyers FJ, Freiha FS, Palmer JM, Shortliffe LD, Hannigan JF, McWhirten KM, Torti FM. Cisplatin, methorexate and vinblastin (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol 1985; 3: 1463–1470.
   PubMed Web of Science ®Google Scholar
• Harmer MH, ed. TNM classification of malignant tumors. Union Internationale Contre le Cancer (IUCC). ed 3. 1978.
   Google Scholar
• Herr HW, Klein EA, Rogatko A. 1991 Local BCG failures in superficial bladder cancer. A multivariate analysis of risk factors influencing survival. Eur Urol 1991; 19: 97–100.
   PubMedGoogle Scholar
• Jakse G, Loidl W, Seeber G, Hofstädter F, Marberger H. Das T1 G III-Urotelkarzinom der Harnblase. Aktuelle Urologi 1985; 16: 304–308.
   Google Scholar
• Logothesis CJ, Samuels ML, Selig DE, Wallace S, Johnson DE. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors. Cancer Treat Rev 1985; 69: 33–38.
   Google Scholar
• Malmström P-U, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer. Scand J Urol Nephrol 1987; 21: 185–195.
   PubMed Web of Science ®Google Scholar
• Montie JE, Straffon RA, Stewart BH. Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 1984; 131: 477–482.
   PubMed Web of Science ®Google Scholar
• Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumor; in Internationale Histological Classification of Tumors. WHO, 1973, No 10.
   Google Scholar
• Natale RB, Yagoda A, Watson RC, Whitmore WF, Blumenreich M, Braun DW. Methotrexate: An active drug in bladder cancer. Cancer 1981; 47: 1246–1250.
   PubMed Web of Science ®Google Scholar
• Neumann MP, Limas C. Transitional cell carcinomas of the urinary bladder. Effect of preoperative irradiation on morphology. Cancer 1986; 58: 2758–2763.
   PubMed Web of Science ®Google Scholar
• Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991; 145: 45–50.
   PubMed Web of Science ®Google Scholar
• Oliver RTD, Newlands ES, Wiltshaw E, Malpas JS. A phase 2 study of cis-platinum in patients with recurrent bladder carcinoma. Br J Urol 1981; 53: 444–447.
   PubMedGoogle Scholar
• Parsons JT, Million RR. Role of planned preoperative irradiation in the management of clinical stage B2-C (T3) bladder carcinoma in the 1980s. Semin Surg Oncol 1989; 5: 255–265.
   PubMedGoogle Scholar
• Scher H, Herr H, Sternberg C, Fair G, Bosl G, Morse M, Sogani P, Watson R, Dershaw D, Reuter V, Curley T, Vaughan EJr, Whitmore W, Yagoda A. Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with MVAC regimen. Br J Urol 1989; 64: 250–256.
   PubMedGoogle Scholar
• Splinter TAW, Denis L, Scher HI, Schröder FH, Dalesio O. Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response. In: Murphy GP, Khoury S, eds Therapeutic progress in urological cancers. New York: Alan R Liss 1989: 541–547.
   Google Scholar
• Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan EDJr, Bander N, Weiselberg LR, Geller N, Hollander PS, Lipperman R, Fair WR, Whitmore WFJr. M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 1988; 139: 461–469.
   PubMed Web of Science ®Google Scholar
• Stöckle M, Alken P, Engelmann U, Jacobi GH, Riedmiller H, Hohenfellner R. Radical cystectomy—often too late? Eur Urol 1987; 13: 361–367.
   PubMed Web of Science ®Google Scholar
• Stoter G, Splinter TA, Child JA, Fosså SD, Denis L, van Oosterom AT, de Pauw M, Sylvester R. Combination chemotherapy with cisplatin and methorexate in advanced transitional cell cancer of the bladder. J Urol 1987; 137: 663–667.
   PubMed Web of Science ®Google Scholar
• Studer E, Hering F, Jaeger P, Mueller J, Schatzmann E, Sonntag RW,Swiss Group for Clinical Cancer Research. Adjuvant cisplatinum chemotherapy following cystectomy for bladder cancer. 22nd Congress of Societe Internationale D'Urologie 1991; 223 (abstract).
   Google Scholar
• Wallace DMA, Raghavan D, Kelly KA, Sandeman TF, Conn IG, Teriana N, Dunn J, Boulas J, Latief T. Neo-adjuvant (Preemptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol 1991; 67: 608–615.
   PubMedGoogle Scholar
• Whitmore WFJr, Batata MA, Ghoneim MA, Grabstald H, Unal A. Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol 1977; 188: 184–187.
   Google Scholar